DC Business DC
Supernus reports mixed ADHD drug trial results. So why isn't it worried?
The Rockville biotech has long been testing a late-stage drug to help treat ADHD.
More from DC Business
Washington Business Journal
Shilling Canning files for bankruptcy protection amid rent struggles
DC Business
•
Apr 24, 2025
Washington Business Journal
Steve Case's Revolution teams with Hilton to deliver luxury Costa Rican resort 19 years in the making
DC Business
•
Apr 23, 2025
Washington Post | Capital Business
Challenge to ACA preventive-care panel draws skepticism from Supreme Court
DC Business
•
Apr 22, 2025
Washington Post | Capital Business
Can Trump remove Powell as Fed chair before his term ends?
DC Business
•
Apr 17, 2025
Washington Business Journal
Amazon closing one of its Northern Virginia supermarkets
DC Business
•
Mar 14, 2025
Washington Business Journal
International travelers give D.C.'s hospitality business only slight boost
DC Business
•
Sep 1, 2022
Washington Post | Capital Business
Drone firm announces Virginia expansion and college partnership
DC Business
•
Aug 24, 2022
Washington Business Journal
Mixed-use development in downtown Bethesda looks to add more retail, residences
DC Business
•
Aug 15, 2022